Xyall: €7.6 Million Raised To Accelerate Global Rollout Of Tissue Dissection System
By Amit Chowdhry ● Feb 16, 2026
Xyall BV, a next-generation innovator in molecular pathology, has raised €7.6 million in new funding to accelerate the global rollout of its automated tissue dissection platform. The financing round was led by Capricorn Partners through its Capricorn Healthtech Fund II, with participation from Sioux Technologies, Brabant Development Agency (BOM), Health Investment Partners, and several private investors.